Dr. Reddy's Laboratories Limited
DRREDDY · National Stock Exchange of India (NSE) · Pharmaceuticals · 美国上市: RDY
公司简介
Dr. Reddy's Laboratories is a leading Indian pharmaceutical company that manufactures and markets generic drugs, active pharmaceutical ingredients, and biosimilars for customers in the US, India, Europe, and other markets. It is among the few Indian drug companies with a significant branded generics presence in Russia and other key emerging markets. The company has invested in biosimilars and specialty pharmaceuticals as future growth drivers.
| 交易所 | National Stock Exchange of India (NSE) |
| 股票代码 | DRREDDY |
| 行业 | Pharmaceuticals |
| 美国上市 | RDY |
| 参考市值 美元 | $12.00B |
| 网站 | 访问官网 |
实时报价
正在加载实时价格……
| 市值 | |
| 当日区间 | |
| 52周区间 |
购买渠道
在美国以RDY交易——可通过大多数美国券商账户购买。
在其本地市场（National Stock Exchange of India (NSE)），可通过以下提供该交易所准入的全球券商进行投资：
- Interactive Brokers — Direct access to 90+ markets worldwide, including many emerging exchanges.
- Saxo Bank — Multi-market access across Asia, Europe and the Middle East.
- Charles Schwab (Global) — Foreign ordinary shares on select markets; US-listed ADRs and ETFs.
- Fidelity International Trading — International stock trading on a number of developed and emerging markets.
- National Stock Exchange of India — 官方交易所上市信息
仅为准入信息参考，不构成推荐或购买要约。请向您的券商确认资格、费用及当前可用性。
India的其他公司
公司数据及任何实时价格均为参考性质，可能存在延迟或不准确，仅供研究参考，不构成投资建议。请以交易所、公司公告及您的券商信息为准。